CORONADO, California — In glaucoma patients, the implantation of an intracanalicular microstent (Hydrus, Ivantis) maintains low intraocular pressure for 2 years and reduces the need for medication, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results